Cargando…
The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations
Cancer patients are susceptible groups to COVID-19, and risk-adjusted models show that most cancer patients have a 25–39% mortality risk if infected with COVID-19. The infection rate of SARS-CoV-2 in cancer patients in China was 0.79% (12 of 1524 patients; 95% CI, 0.31.2%). The case fatality rate of...
Autores principales: | Abdihamid, Omar, Cai, Changjing, Kapesa, Linda, Zeng, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520115/ https://www.ncbi.nlm.nih.gov/pubmed/33061588 http://dx.doi.org/10.2147/CMAR.S272008 |
Ejemplares similares
-
Which cancer type has the highest risk of COVID-19 infection?
por: Cai, Changjing, et al.
Publicado: (2020) -
A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy
por: Cai, Changjing, et al.
Publicado: (2020) -
Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Rugambwa, Tibera K., et al.
Publicado: (2023) -
Lauren classification and individualized chemotherapy in gastric cancer
por: MA, JUNLI, et al.
Publicado: (2016) -
US Cancer Screening Recommendations: Developments and the Impact of COVID-19
por: Barsouk, Adam, et al.
Publicado: (2022)